×
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
ETR:GXI

Gerresheimer Stock Forecast, Price & News

€66.90
+0.25 (+0.38%)
(As of 06/28/2022 12:00 AM ET)
Add
Compare
Today's Range
€66.25
€67.35
50-Day Range
€63.50
€73.50
52-Week Range
€53.45
€99.40
Volume
47,512 shs
Average Volume
140,925 shs
Market Capitalization
$2.10 billion
P/E Ratio
24.59
Dividend Yield
1.82%
Price Target
€99.55
30 days | 90 days | 365 days | Advanced Chart

Receive GXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

GXI Stock Forecast (MarketRank)

Overall MarketRank

2.03 out of 5 stars

Analyst Opinion: 2.0Community Rank: 4.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -
Gerresheimer logo

About Gerresheimer (ETR:GXI)

Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

GXI Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
10,447
Year Founded
N/A

Company Calendar

Today
6/29/2022
Next Earnings (Estimated)
7/13/2022

Price Target and Rating

Average Stock Price Forecast
€99.55
High Stock Price Forecast
€115.00
Low Stock Price Forecast
€66.30
Forecasted Upside/Downside
+48.8%
Consensus Rating
N/A
Rating Score (0-4)
3
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.57 billion
Cash Flow
€3.33 per share
Book Value
€32.94 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.10 billion
Optionable
Not Optionable
Beta
N/A














Gerresheimer Frequently Asked Questions

What is Gerresheimer's stock price forecast for 2022?

0 equities research analysts have issued 12 month price targets for Gerresheimer's stock. Their GXI stock forecasts range from €66.30 to €115.00. On average, they expect Gerresheimer's stock price to reach €99.55 in the next year. This suggests a possible upside of 48.8% from the stock's current price.
View analysts' price targets for Gerresheimer
or view top-rated stocks among Wall Street analysts.

How has Gerresheimer's stock price performed in 2022?

Gerresheimer's stock was trading at €84.70 at the beginning of 2022. Since then, GXI stock has decreased by 21.0% and is now trading at €66.90.
View the best growth stocks for 2022 here
.

When is Gerresheimer's next earnings date?

Gerresheimer is scheduled to release its next quarterly earnings announcement on Wednesday, July 13th 2022.
View our earnings forecast for Gerresheimer
.

Is Gerresheimer a good dividend stock?

Gerresheimer(ETR:GXI) pays an annual dividend of €1.25 per share and currently has a dividend yield of 1.82%. The dividend payout ratio of Gerresheimer is 45.94%. This payout ratio is at a healthy, sustainable level, below 75%.

Who are Gerresheimer's key executives?

Gerresheimer's management team includes the following people:
  • Mr. Dietmar Siemssen, CEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board (Age 59, Pay $1.91M)
  • Dr. Bernd Metzner Ph.D., CFO & Member of the Management Board (Age 52, Pay $1.19M)
  • Dr. Lukas Burkhardt, Member of the Management Board (Age 43, Pay $1.16M)
  • Ms. Katja Schnitzler, Member of Supervisory Board (Age 41, Pay $106k)
  • Ms. Carolin Nadilo, Corp. Director of Investor Relations
  • Mr. Helmut Schweiger, MD & GM of Gerresheimer Horsovsky Tyn Plant

What other stocks do shareholders of Gerresheimer own?

What is Gerresheimer's stock symbol?

Gerresheimer trades on the ETR under the ticker symbol "GXI."

What is Gerresheimer's stock price today?

One share of GXI stock can currently be purchased for approximately €66.90.

How much money does Gerresheimer make?

Gerresheimer (ETR:GXI) has a market capitalization of $2.10 billion and generates $1.57 billion in revenue each year.

How many employees does Gerresheimer have?

Gerresheimer employs 10,447 workers across the globe.

How can I contact Gerresheimer?

Gerresheimer's mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The official website for Gerresheimer is www.gerresheimer.com. The company can be reached via phone at +49-211-618100.

This page (ETR:GXI) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.